TY - JOUR
T1 - Natriuretic peptides in the prognosis and management of acute coronary syndromes
AU - de Lemos, James A
AU - Frank Peacock, W.
AU - McCullough, Peter A.
PY - 2010/3
Y1 - 2010/3
N2 - Over the past decade, an evidence base has accumulated to support natriuretic peptide (NP) testing for diagnosis, risk assessment, and therapeutic monitoring and guidance of patients with heart failure. Investigators have also explored multiple other potential uses for these tests, including risk assessment of patients with suspected acute coronary syndromes (ACS). This article discusses the utility of NPs in the diagnosis and management of patients with ACS.
AB - Over the past decade, an evidence base has accumulated to support natriuretic peptide (NP) testing for diagnosis, risk assessment, and therapeutic monitoring and guidance of patients with heart failure. Investigators have also explored multiple other potential uses for these tests, including risk assessment of patients with suspected acute coronary syndromes (ACS). This article discusses the utility of NPs in the diagnosis and management of patients with ACS.
KW - Acute coronary syndromes
KW - Management strategies
KW - Natriuretic peptides
KW - Risk assessment
UR - http://www.scopus.com/inward/record.url?scp=77958122557&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77958122557&partnerID=8YFLogxK
U2 - 10.3909/ricm11S2S0004
DO - 10.3909/ricm11S2S0004
M3 - Review article
C2 - 20700099
AN - SCOPUS:77958122557
SN - 1530-6550
VL - 11
SP - S24-S34
JO - Reviews in Cardiovascular Medicine
JF - Reviews in Cardiovascular Medicine
IS - SUPPL. 2
ER -